NO20003150D0 - FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging - Google Patents

FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging

Info

Publication number
NO20003150D0
NO20003150D0 NO20003150A NO20003150A NO20003150D0 NO 20003150 D0 NO20003150 D0 NO 20003150D0 NO 20003150 A NO20003150 A NO 20003150A NO 20003150 A NO20003150 A NO 20003150A NO 20003150 D0 NO20003150 D0 NO 20003150D0
Authority
NO
Norway
Prior art keywords
chewing
procedure
preparation
tablets dissolved
tablets
Prior art date
Application number
NO20003150A
Other languages
English (en)
Other versions
NO20003150L (no
Inventor
Gopadi M Venkatesh
Nageswara R Palepu
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20003150D0 publication Critical patent/NO20003150D0/no
Publication of NO20003150L publication Critical patent/NO20003150L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003150A 1997-12-19 2000-06-16 FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging NO20003150L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6825897P 1997-12-19 1997-12-19
PCT/US1998/027061 WO1999032092A1 (en) 1997-12-19 1998-12-17 Process for manufacturing bite-dispersion tablets

Publications (2)

Publication Number Publication Date
NO20003150D0 true NO20003150D0 (no) 2000-06-16
NO20003150L NO20003150L (no) 2000-08-11

Family

ID=22081416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003150A NO20003150L (no) 1997-12-19 2000-06-16 FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging

Country Status (20)

Country Link
US (1) US6475510B1 (no)
EP (1) EP1047407A4 (no)
JP (1) JP2001526212A (no)
KR (1) KR100775154B1 (no)
CN (1) CN100379407C (no)
AR (1) AR014133A1 (no)
AU (2) AU1931999A (no)
BR (1) BR9813808A (no)
CA (1) CA2315088A1 (no)
CO (1) CO4990940A1 (no)
HU (1) HUP0100469A2 (no)
IL (2) IL136831A0 (no)
NO (1) NO20003150L (no)
NZ (1) NZ505123A (no)
PL (1) PL197989B1 (no)
SA (1) SA99191111B1 (no)
TR (1) TR200001856T2 (no)
TW (1) TW586943B (no)
WO (1) WO1999032092A1 (no)
ZA (1) ZA9811630B (no)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
ES2257869T3 (es) * 1998-08-21 2006-08-01 Novartis Ag Nueva formulacion oral para agonistas o antagonistas de 5-ht4.
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
US7939105B2 (en) * 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US7223416B2 (en) * 1999-06-28 2007-05-29 Minu, L.L.C. Topical composition
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
IT1313589B1 (it) * 1999-08-03 2002-09-09 Formenti Farmaceutici Spa Composizioni a rilascio controllato di paracetamolo.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20020022058A1 (en) * 2000-07-08 2002-02-21 Lovercheck Dale R. Unit dose of material in system and method
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
JP4868695B2 (ja) * 2000-09-22 2012-02-01 大日本住友製薬株式会社 崩壊性が良好な経口製剤
AU2002221939A1 (en) * 2000-12-07 2002-06-18 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Rapidly disintegrating tablet comprising an acid-labile active ingredient
WO2002049607A2 (en) * 2000-12-20 2002-06-27 Firmenich Sa Flavoured oral drug delivery system
US20030060451A1 (en) * 2001-05-29 2003-03-27 Rajneesh Taneja Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithin
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
CA2447984A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Dosage forms having an inner core and outer shell with different shapes
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6982094B2 (en) * 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
HRP20040322A2 (en) * 2001-10-09 2004-12-31 Bristol Myers Squibb Co Flashmelt oral dosage formulation
US6610266B2 (en) 2001-11-28 2003-08-26 Michael C. Withiam Calcium metasilicates and methods for making
AU2003209475A1 (en) * 2002-03-07 2003-09-16 Vectura Limited Fast melt multiparticulate formulations for oral delivery
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
JP3444874B1 (ja) * 2002-12-02 2003-09-08 高砂香料工業株式会社 顆粒状香料およびその製造方法
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
FR2848855B1 (fr) * 2002-12-23 2005-02-11 Aventis Pharma Sa Compositions pour administration orale de principes actifs necessitant un masquage du gout
US20040146553A1 (en) * 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
CN100415269C (zh) * 2002-12-30 2008-09-03 毛友昌 牛黄蛇胆川贝分散片及制备方法
CN1303979C (zh) * 2003-03-21 2007-03-14 毛友昌 蛇胆陈皮分散片及制备方法
CA2521253A1 (en) * 2003-04-02 2004-10-14 Pliva Istrazivanje I Razvoj D.O.O. Pharmaceutical compositions having reduced bitter taste
AU2003300694A1 (en) * 2003-04-17 2004-11-04 Ipca Laboratories Limited Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
US7282217B1 (en) * 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
TW200524541A (en) * 2003-11-17 2005-08-01 Cargill Inc Lecithin-containing granular compositions and methods of their preparation
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
US8337887B2 (en) 2004-03-11 2012-12-25 Laboratories Pharmaceutiques Rodael Rapidly disintegrating taste-masked tablet
KR101269766B1 (ko) 2004-03-30 2013-05-30 리립사, 인크. 이온 결합 중합체 및 이의 용도
CA2557999C (en) 2004-03-30 2013-11-12 Ilypsa, Inc. Methods and compositions for treatment of ion imbalances
WO2005104868A1 (ja) * 2004-04-30 2005-11-10 Bio Science Co., Ltd. 反芻動物用飼料添加組成物及びこれを含有する飼料並びに反芻動物用飼料添加組成物の製造方法
US10258576B2 (en) 2004-05-24 2019-04-16 Takeda As Particulate comprising a calcium-containing compound and a sugar alcohol
JP4996458B2 (ja) * 2004-06-01 2012-08-08 ニコメド ファーマ エイエス 活性物質としてカルシウム含有化合物を含み、咀嚼し、舐め、飲み込むことのできる錠剤
CA2568640C (en) 2004-06-04 2011-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
US20060024335A1 (en) * 2004-07-29 2006-02-02 Roger Stier E Oral compositions which mask the bitter taste of a bitter-tasting agent
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
ES2255429B1 (es) * 2004-10-25 2007-08-16 Italfarmaco, S.A. Composiciones farmaceuticas bucodispersables.
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
US20060263429A1 (en) 2005-05-20 2006-11-23 Hengsheng Feng Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
AU2006299449B2 (en) 2005-09-30 2013-07-04 Relypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
JP2009510233A (ja) 2005-09-30 2009-03-12 レリプサ， インコーポレイテッド 架橋シェルを有するコア−シェルコンポジットを製造する方法および該方法によって生じたコア−シェルコンポジット
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
CN102872157A (zh) * 2005-12-07 2013-01-16 奈科明制药有限公司 预先压实的含钙组合物
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
CN100502842C (zh) * 2006-08-31 2009-06-24 山东益康药业有限公司 尼扎替丁分散片及其制备方法
EP1952803A1 (en) 2007-01-23 2008-08-06 KTB-Tumorforschungs GmbH Solid pharmaceutical dosage form containing hydrogenated phospholipids
US20100016322A1 (en) * 2007-02-28 2010-01-21 Nagesh Nagaraju Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
JP2008297277A (ja) * 2007-06-01 2008-12-11 Taiyo Yakuhin Kogyo Kk 注射剤の安定化法
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
TWI468167B (zh) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 藥學組成物
WO2009150665A1 (en) * 2008-06-09 2009-12-17 Lupin Limited Orally disintegrating pharmaceutical compositions of escitalopram and salts thereof
RU2663017C2 (ru) * 2009-01-23 2018-08-01 ВАЙЕТ ЭлЭлСи Пищевые добавки для лиц в возрасте 50 лет и старше для повышения жизнеспособности, иммунитета, здоровья глаз и костей
BR112012012656A2 (pt) * 2009-11-25 2015-09-15 Cargill Inc composicoes adocantes e seu processo de fabricacao
KR101765357B1 (ko) * 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
SG191145A1 (en) 2010-12-13 2013-07-31 Borody Thomas J Gastric and colonic formulations and methods for making and using them
US20120276199A1 (en) * 2011-04-01 2012-11-01 Dr. Reddy's Laboratories Limited Taste masked pharmaceutical formulations
EP2742350B1 (en) 2011-08-08 2019-10-30 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
DE102011115173A1 (de) * 2011-08-12 2013-02-14 Ipc Process-Center Gmbh & Co. Kg Koffein enthaltendes Granulat und Verfahren zu seiner Herstellung
WO2013175511A1 (en) * 2012-05-24 2013-11-28 V.B. Medicare Pvt. Ltd. Taste masked pharmaceutical compositions
WO2014016671A2 (en) * 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
CN104366313A (zh) * 2013-08-15 2015-02-25 珠海市红旌发展有限公司 一种红薯叶咀嚼片
NZ737945A (en) 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
RS57328B1 (sr) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JP6145954B1 (ja) * 2016-09-06 2017-06-14 株式会社東洋新薬 飲食用組成物
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US10925853B2 (en) 2019-04-17 2021-02-23 Nordiccan A/S Oral cannabinoid tablet
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US20250213468A1 (en) * 2021-12-03 2025-07-03 Pharmachem Laboratories, Llc An organic chewable composition comprising certified organic ingredients, and process for preparing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
CN1055877A (zh) * 1990-04-20 1991-11-06 国家医药管理局上海医药工业研究院 中药咀嚼片的制备方法
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
DE69331378D1 (de) * 1992-02-18 2002-01-31 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von schnelllöslicher Tabletten und schnelllöslichen Tablette beinhaltend Xylitol
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
JP2841267B2 (ja) * 1993-12-17 1998-12-24 エスエス製薬株式会社 イブプロフェン含有粒剤
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
CN1192137A (zh) 1995-07-31 1998-09-02 格哈特·格戈里 有泡腾效应的咀嚼片剂
DE19534368A1 (de) * 1995-09-15 1997-03-20 Pedex & Co Gmbh Borsten mit Oberflächenstruktur und Verfahren zu ihrer Herstellung
FR2786665B1 (fr) * 1998-12-08 2001-02-23 Maurel Sante Compositions de type fondant a base de polyols, compositions pharmaceutiques et complements alimentaires incluant de telles compositions et leurs procedes de preparation

Also Published As

Publication number Publication date
EP1047407A4 (en) 2007-05-02
SA99191111A (ar) 2005-12-03
WO1999032092A1 (en) 1999-07-01
EP1047407A1 (en) 2000-11-02
CO4990940A1 (es) 2000-12-26
PL341353A1 (en) 2001-04-09
US6475510B1 (en) 2002-11-05
IL136831A0 (en) 2001-06-14
CN100379407C (zh) 2008-04-09
AU2002300238C1 (en) 2004-03-04
PL197989B1 (pl) 2008-05-30
AU2002300238B2 (en) 2003-01-02
CN1284867A (zh) 2001-02-21
SA99191111B1 (ar) 2006-10-11
ZA9811630B (en) 1999-06-21
IL136831A (en) 2006-12-10
KR100775154B1 (ko) 2007-11-12
HUP0100469A2 (hu) 2001-08-28
BR9813808A (pt) 2002-05-28
NO20003150L (no) 2000-08-11
TR200001856T2 (tr) 2000-11-21
JP2001526212A (ja) 2001-12-18
NZ505123A (en) 2003-07-25
AR014133A1 (es) 2001-02-07
KR20010033328A (ko) 2001-04-25
CA2315088A1 (en) 1999-07-01
TW586943B (en) 2004-05-11
AU1931999A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
NO20003150L (no) FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging
DK1117411T3 (da) Fremgangsmåde til fremstilling af orale farmaceutiske præparater som omfatter biphosphonater
NO20005043L (no) Formulering av hurtigoppløsende efavirenz-kapsler eller - tabletter som benytter super-desintegreringsmidler
NO994771D0 (no) FremgangsmÕte ved fremstilling av oligosakkarider
DK0747116T3 (da) Fremgangsmåde til fremstilling af mikrokapselsammensætninger
NO971137D0 (no) Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser
NO990435L (no) Fremstilling av estere som overflateaktive midler
NO20004288L (no) FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20002247D0 (no) FremgangsmÕte for fremstilling av aromatiske nitroforbindelser
NO20023937L (no) Fremgangsmåte for fremstilling av substituert tiazolidindion
NO993912D0 (no) Fremgangsmåte for fremstilling av eprosartan
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO993913D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
NO994131D0 (no) Fremgangsmåte for fremstilling av benzotiazolonforbindelser
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application